CYRANO THERAPEUTICS
Cyrano Therapeutics is a private, venture-backed clinical stage regenerative medicine company. The Company is working diligently to develop therapies for people struggling with the loss of smell and taste. Cyrano is working to advance the development of CYR-064 as a potential first-ever treatment for post-viral smell loss (hyposmia)
Disclaimer : All logos and trademarks on this website are the property of their respective owners. The information on this website is not a medical or investment related advice. The information about the company might not reflect the most current or accurate information. Please refer to the company's respective website for the most accurate information.